This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Ink and Chemicals, Incorporated. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovations of Hiroshi Araya
Hiroshi Araya is a notable inventor based in Gotenba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on quinolinone derivatives. His research and inventions have the potential to impact the medical industry positively.
Latest Patents
Hiroshi Araya holds a patent for a quinolinone derivative pharmaceutical composition and its production method. This composition comprises a quinolinone derivative represented by a specific structural formula. The particles of this derivative have an average diameter ranging from 0.5 to 10 micrometers, with 90% or more of the particles measuring 15 micrometers or less. Additionally, these particles exhibit a fusion enthalpy of 30 J/g or more. The surface of the particles is coated with a water-soluble composition containing a water-soluble polymer, which allows for quick dissolution of the active ingredient in the digestive tract and enhances long-term storage stability. This patent showcases his innovative approach to pharmaceutical formulations.
Career Highlights
Hiroshi Araya is associated with Dainippon Ink and Chemicals, Incorporated, where he has been able to apply his expertise in developing pharmaceutical compositions. His work has contributed to advancements in drug formulation and delivery systems.
Collaborations
Hiroshi has collaborated with notable colleagues, including Ryuji Kubota and Kouki Obata. These collaborations have likely fostered a creative environment that encourages innovation and the development of new ideas in the pharmaceutical field.
Conclusion
Hiroshi Araya's contributions to the pharmaceutical industry through his innovative patent on quinolinone derivatives highlight his role as a significant inventor. His work not only demonstrates his expertise but also has the potential to improve drug formulations and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile